文献速递垂体与肾上腺疾病

膳食钠限制增加对原发性醛固酮增多症轻度病例的误判风险

Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2016-07-18

研究评估膳食钠限制是否导致原发性醛固酮增多症(PA)筛查的误判。241例高膳食钠摄入(HS)下ARR>20的未治疗高血压患者同时接受低膳食钠摄入(LS)评估。结果显示LS可使部分患者ARR正常化,轻度PA表型最易受膳食钠影响,最佳筛查应在HS条件下进行。

要点

  • HS下ARR>20的未治疗高血压患者中,仅33%(79/241)筛查阳性。
  • LS下56%(44/79)的HS筛查阳性者不再符合PA筛查阳性标准。
  • 经确认的48例PA中,52%在LS下筛查为阴性。

核心结论

  • 膳食钠限制可显著升高血浆肾素活性(PRA)、使ARR正常化,导致PA筛查的假性解读。
  • PRA未被充分抑制的轻度PA表型最易受膳食钠对肾素和ARR的影响。
  • 最佳PA筛查应在高膳食钠摄入条件下进行。

研究设计与样本

  • 研究纳入241例未治疗高血压患者,其在高膳食钠摄入(HS)下ARR>20,并同时在低膳食钠摄入(LS)下评估。
  • PA筛查阳性定义为:血浆肾素活性(PRA)≤1.0 ng/mL·h且血清醛固酮≥6 ng/dL。
  • PA确诊依据:24小时尿醛固酮排泄≥12 mcg且尿钠>200 mmol。

主要发现

  • HS下ARR>20的参与者中,仅33%(79/241)PA筛查阳性。
  • LS下,56%(44/79)的HS筛查阳性参与者不再符合PA筛查阳性标准。
  • 与两种饮食下均筛查阳性的参与者相比,HS阳性但LS阴性的参与者在两种饮食下PRA均显著更高。
  • 79例中48例确诊PA,其中52%在LS下筛查为阴性。
  • 筛查结果「不一致」的参与者特征为:LS下PRA升高幅度更大导致ARR正常化,且白种人比例更高。

关键数值与推荐

  • PA筛查阳性:PRA≤1.0 ng/mL·h且血清醛固酮≥6 ng/dL。
  • PA确诊:24小时尿醛固酮排泄≥12 mcg且尿钠>200 mmol。
  • HS下ARR>20的未治疗高血压患者中,仅33%(79/241)筛查阳性。
  • LS下56%(44/79)的HS筛查阳性者不再符合PA筛查阳性标准。
  • 确诊PA的48例中,52%在LS下筛查为阴性。

临床怎么用

  • 高血压患者推荐限制钠摄入;但钠限制可显著升高PRA、使ARR正常化,导致PA筛查的假性解读。
  • 最佳PA筛查应在高膳食钠摄入条件下进行。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The aldosterone to renin ratio (ARR) is recommended to screen for primary aldosteronism (PA). OBJECTIVE: To evaluate whether dietary sodium restriction results in misinterpretation of PA screening. PARTICIPANTS: Untreated hypertensives with ARR more than 20 on a high dietary sodium intake (HS) were also evaluated on a low dietary sodium intake (LS) (n = 241). Positive screening for PA was defined as: plasma renin activity (PRA) less than or equal to 1.0 ng/mL · h with serum aldosterone more than or equal to 6 ng/dL. PA was confirmed by a 24-hour urinary aldosterone excretion more than or equal to 12 mcg with urinary sodium more than 200 mmol. RESULTS: Only 33% (79/241) of participants with an ARR more than 20 had a positive PA screen on HS. On LS, 56% (44/79) of these participants no longer met criteria for positive PA screening. When compared with participants with positive PA screening on both diets, participants with a positive screen on HS but negative on LS exhibited a significantly higher PRA on both diets. Remarkably, of the 48/79 participants who had PA confirmed, 52% had negative PA screening on LS. The distinguishing feature of these participants with "discordant" screening results was a larger rise in PRA on LS resulting in normalization of the ARR and higher Caucasian race prevalence. CONCLUSIONS: Sodium restriction is recommended in hypertension; however, it can significantly raise PRA, normalize the ARR, and result in false interpretation of PA screening. Milder phenotypes of PA, where PRA is not as suppressed, are most susceptible to dietary sodium influences on renin and ARR. Optimal screening for PA should occur under conditions of HS.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Baudrand R, Guarda FJ, Torrey J, et al. Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism. J Clin Endocrinol Metab. 2016. PMID: 27428770

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。